Technological advancement in sensing devices and introduction of key players into the market is expected to boost the growth of Wearable Sensors Market
High intake of alcohol and drugs is major cause of snoring, which is expected to augment the anti-snoring treatment market growth
Rising prevalence of muscular dystrophies with unspecific current medications is expected to fuel the muscular dystrophies treatment market
Laboratory Equipment Market, By Equipment Type (General Instrument, Analytical Instrument, Specialty Instrument), By End User (Academic Laboratory, Research Laboratory, Pharmaceutical Laboratory) - Gl...
Targeted cancer therapies market is growing due to the increasing incidences of cancers such as breast cancer, lung cancer, colorectal and among others.
Increasing R&D activities to launch new products is expected to support in growth of the cardiovascular drugs market
Rapid product launch and frequent approval of novel spinal fusion devices are expected to drive growth of the global spinal fusion market
Personalized medicine and advanced technologies such as assay performance and drug monitoring to fuel the growth of therapeutic drug monitoring market
Development of first-of-its-kind therapeutic approach to treat carcinoid syndrome diarrhea creates highly lucrative growth opportunities for market players.
Introduction of novel immune-oncology therapies with lesser side effects is driving growth of the global immune-oncology drugs market
Development of technologically advanced cardiac monitoring devices is expected to boost the cardiac monitoring devices market growth
Increasing prevalence of diabetes and robust development in technology is expected to drive growth of the market over the forecast period
The global pulmonary drugs market was valued at US$ 28.1 billion in 2016 and is expected to witness a robust CAGR of 8.1% over the forecast period (2017 - 2025).
Rapid approval of biosimilars for oncology is expected to be a major driving factor for growth of the oncology biosimilars market over the forecast period
The global triptorelin market size was valued at US$ 426.4 Mn in 2017, and is expected to witness a CAGR of 5.2% over the forecast period (2018 – 2026).